D. E. Shaw & Co., Inc. Teva Pharmaceutical Industries LTD Put Options Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $500,976 - $682,080	39,200 Added 33.62%	155,800 $2.53 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $2.51 Million - $3.39 Million	-235,000 Reduced 66.84%	116,600 $1.65 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $974,399 - $1.28 Million	-120,000 Reduced 25.45%	351,600 $3.67 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $561,000 - $802,500	75,000 Added 18.91%	471,600 $4.81 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $1.09 Million - $1.44 Million	151,600 Added 61.88%	396,600 $2.99 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $7.98 Million - $10.9 Million	-955,000 Reduced 79.58%	245,000 $2.17 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $2.39 Million - $2.84 Million	300,000 Added 33.33%	1,200,000 $10.9 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $963,090 - $1.36 Million	-130,500 Reduced 12.66%	900,000 $6.77 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $986,618 - $1.26 Million	-134,600 Reduced 11.55%	1,030,500 $9.68 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $2.14 Million - $2.76 Million	270,500 Added 30.24%	1,165,100 $9.33 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $6.24 Million - $7.58 Million	744,600 Added 496.4%	894,600 $8.71 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $495,000 - $578,000	-50,000 Reduced 25.0%	150,000 $1.49 Million
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $10.5 Million - $13 Million	-1,014,800 Reduced 83.54%	200,000 $2.31 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $2.04 Million - $2.62 Million	-236,900 Reduced 16.32%	1,214,800 $11.7 Million
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $1.34 Million - $1.99 Million	156,900 Added 12.12%	1,451,700 $13.1 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $950,039 - $1.54 Million	-117,000 Reduced 8.29%	1,294,800 $16 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $9.47 Million - $19 Million	-1,416,100 Reduced 50.08%	1,411,800 $12.7 Million
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $7.38 Million - $12.1 Million	-1,129,500 Reduced 28.54%	2,827,900 $27.7 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $5.79 Million - $9.02 Million	940,000 Added 31.15%	3,957,400 $27.2 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $16.4 Million - $31.7 Million	2,016,700 Added 201.53%	3,017,400 $27.9 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $40.1 Million - $51.6 Million	-2,576,300 Reduced 72.02%	1,000,700 $15.7 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $9.05 Million - $14.8 Million	-620,000 Reduced 14.77%	3,577,000 $55.2 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $2.11 Million - $2.57 Million	-100,000 Reduced 2.33%	4,197,000 $90.4 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $14.4 Million - $21.1 Million	-855,700 Reduced 16.61%	4,297,000 $105 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $3.92 Million - $5.19 Million	235,000 Added 4.78%	5,152,700 $88.1 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $21.4 Million - $36.4 Million	1,906,700 Added 63.32%	4,917,700 $93.2 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $46.4 Million - $96.9 Million	3,011,000	3,011,000 $53 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$736 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$622 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$553 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$493 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$453 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account